# PALYNZIQ
> **BLA761079** · Biologics License Application · Sponsor: BIOMARIN PHARM · Approved 2018-05-24
## Drug
- **FDA Application Number:** BLA761079
- **Application type:** Biologics License Application
- **Brand name:** PALYNZIQ
- **Generic name:** PEGVALIASE-PQPZ
- **Active ingredients:** PEGVALIASE-PQPZ
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** BIOMARIN PHARM
- **Manufacturer:** BioMarin Pharmaceutical Inc.
- **First approval:** 2018-05-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761079)
---
*MORVS · CC0 1.0*